BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35864365)

  • 21. A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction.
    Varghese J; Gohari SS; Rizki H; Faheem M; Langridge B; Kümmel S; Johnson L; Schmid P
    Breast; 2021 Feb; 55():55-62. PubMed ID: 33341706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools.
    Righi A; Pacheco M; Palmerini E; Carretta E; Gambarotti M; Longhi A; Magagnoli G; Sbaraglia M; Manfrini M; Picci P; Dei Tos AP
    Eur J Surg Oncol; 2021 Jul; 47(7):1778-1783. PubMed ID: 33622576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study.
    Tang H; Liu D; Lu J; He J; Ji S; Liao S; Wei Q; Lu S; Liu Y
    BMC Cancer; 2022 Jan; 22(1):33. PubMed ID: 34983443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of interval timing to surgery on tumor response after neoadjuvant treatment for gastric cancer.
    Ocaña Jiménez J; Priego P; Cuadrado M; Blázquez LA; Sánchez Picot S; Pastor Peinado P; Longo F; López F; Caminoa-Lizarralde MA; Galindo J
    Rev Esp Enferm Dig; 2020 Aug; 112(8):598-604. PubMed ID: 32496120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.
    Jamshidi K; Ramezan Shirazi M; Bagherifard A; Mirzaei A
    Int Orthop; 2019 Feb; 43(2):467-473. PubMed ID: 30099643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?
    Bedi M; Ethun CG; Charlson J; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; King DM
    Clin Orthop Relat Res; 2020 Mar; 478(3):550-559. PubMed ID: 32168066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative evaluation and monitoring chemotherapy in patients with high-grade osteogenic and Ewing's sarcoma: review of current imaging modalities.
    van der Woude HJ; Bloem JL; Hogendoorn PC
    Skeletal Radiol; 1998 Feb; 27(2):57-71. PubMed ID: 9526770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating readmission rates for patients undergoing oncologic resection and endoprosthetic reconstruction for primary sarcomas and tumors involving bone.
    Lazarides AL; Flamant EM; Cullen MM; Ferlauto HR; Cochrane N; Gao J; Jung SH; Visgauss JD; Brigman BE; Eward WC
    J Surg Oncol; 2022 Aug; 126(2):356-364. PubMed ID: 35319106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
    Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
    Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
    Ray GS; Werth P; Alexander JH; Eward WC; Bernthal NM; Jeys LM; Funovics P; Windhager R; Temple HT; Lozano-Calderon S; Avedian RS; Jutte PC; Ghert M; Ruggieri P; Henderson ER;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):87-96. PubMed ID: 37466585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal timing of surgery following breast cancer neoadjuvant chemotherapy: A systematic review and meta-analysis.
    Cullinane C; Shrestha A; Al Maksoud A; Rothwell J; Evoy D; Geraghty J; McCartan D; McDermott EW; Prichard RS
    Eur J Surg Oncol; 2021 Jul; 47(7):1507-1513. PubMed ID: 33589241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing Laparotomy with Robot-assisted Interval Debulking Surgery for Patients with Advanced Epithelial Ovarian Cancer Receiving Neoadjuvant Chemotherapy.
    Zhang Y; Grant MS; Zhang X; Paraghamian SE; Tan X; Clark LH
    J Minim Invasive Gynecol; 2021 Jun; 28(6):1237-1243. PubMed ID: 33248314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
    Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
    J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancer.
    Kanbergs AN; Manning-Geist BL; Pelletier A; Sullivan MW; Del Carmen MG; Horowitz NS; Growdon WB; Clark RM; Muto MG; Worley MJ
    Gynecol Oncol; 2020 Dec; 159(3):687-691. PubMed ID: 32951891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstructive outcome analysis of the impact of neoadjuvant chemotherapy on immediate breast reconstruction: a retrospective cross-sectional study.
    Yang JR; Kuo WL; Yu CC; Chen SC; Huang JJ
    BMC Cancer; 2021 May; 21(1):522. PubMed ID: 33964927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
    Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
    [No Abstract]   [Full Text] [Related]  

  • 39. Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer.
    Tamandl D; Gore RM; Fueger B; Kinsperger P; Hejna M; Paireder M; Haug A; Schoppmann SF; Ba-Ssalamah A
    Eur Radiol; 2016 Feb; 26(2):311-21. PubMed ID: 26040648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.
    Sofulu Ö; Erol B
    Acta Orthop Traumatol Turc; 2020 May; 54(3):234-244. PubMed ID: 32544060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.